Status and phase
Conditions
Treatments
About
To evaluate the safety,tolerability,pharmacokinetic characteristics and preliminary efficacy of HR19024 injection in the treatment of advanced solid tumor
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
180 participants in 1 patient group
Loading...
Central trial contact
Hao Geng
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal